Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Squamous Cell Carcinoma of Head and Neck 12Oropharyngeal Neoplasms 11Lung Neoplasms 8Laryngeal Neoplasms 8Carcinoma 8Mouth Neoplasms 7Carcinoma, Non-Small-Cell Lung 7Hypopharyngeal Neoplasms 6Nasopharyngeal Carcinoma 5Mesothelioma, Malignant 5Urinary Bladder Neoplasms 4Pancreatic Neoplasms 4Uterine Cervical Neoplasms 3Lymphoid Interstitial Pneumonia 3Gallbladder Neoplasms 3Triple Negative Breast Neoplasms 2Salivary Gland Neoplasms 2Paranasal Sinus Neoplasms 2Ovarian Neoplasms 2Medulloblastoma 2Ganglioneuroblastoma 2Cholangiocarcinoma 2Adenocarcinoma of Lung 2Vulvar Neoplasms 1Vaginal Neoplasms 1Tongue Neoplasms 1Testicular Neoplasms 1Teratoma 1Stomatitis 1Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7 1

Interventions

pembrolizumab 1X-Rays 1Taxes 1Specimen Handling 1Radiotherapy, Intensity-Modulated 1Radiation 1Platinum 1Paclitaxel 1Magnetic Resonance Spectroscopy 1Congresses as Topic 1Cisplatin 1Carboplatin 1Brachytherapy 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Locally Advanced Cervical Adenocarcinoma × 1,2-diaminocyclohexaneplatinum II citrate × 90 days × Clear all
NCT07061977 2026-06-03

Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer

National Cancer Institute (NCI)

Phase 3 Recruiting
336 enrolled
Gynecologic

Locally Advanced Cervical Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡